Stephanie YEO

Matters of significance in which Stephanie has been involved in include:

• Acting as lead counsel for the Japanese bankruptcy trustee in Re Opti Medix (in liquidation) and another matter [2016] SGHC 108, a landmark decision recognizing the trustee’s appointment over two British Virgin Islands companies that was nominated for Most Important Recognition Decision in the Global Restructuring Review Awards 2017.
• Acting as one of the lead partners in the US$3.3 billion restructuring of Pacific International Lines which involved a combination of an in-court restructuring of over US$1 billion through one of the largest and most complex schemes of arrangement to be sanctioned by the Singapore court since the implementation of the new restructuring regime in Singapore as well as an out-of-court restructuring of the company’s remaining debts. The restructuring also involved a US$600 million investment by Heliconia Capital Management through a combination of debt and equity instruments.
• Acting for the ad hoc committee of bondholders in respect of the cross-border restructuring of Noble Group Limited.
• Acting for and advising the judicial manager of Altus Shipping & Logistics Pte Ltd, an international conglomerate which involved a novel credit-bid structure for the acquisition of the assets.
• Acting for the former shareholders of a public-listed multinational pharmaceutical company, in an application to set aside an arbitration award granting damages amounting to more than US$500 million against them: [2018] SGHC 275.
• Acting for Indian Senior Advocate, Mr Harish Salve, in the first application ever made to the Singapore courts for ad hoc admission of an Indian Senior Advocate: [2017] SGHC 28.

Related Practices

• Restructuring & Insolvency
• Special Situations Advisory